|
ANVS Annovis Bio Inc 1477845 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-17,606,382.00 |
| Balance Sheet |
|
Current Assets
|
$7,813,295.00 |
|
Assets
|
$16,243,703.00 |
|
Current Liabilities
|
$12,790,645.00 |
|
Liabilities
|
$13,117,645.00 |
|
Equity
|
$3,126,058.00 |
|
Shares Out
|
28537302.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,011,624.00 |
| Market Analysis |
Market Cap
|
$50,511,024.54 |
|
Price
|
$1.77 |
|
BVPS
|
0.11 |
|
PB
|
16.09 |
|
EPS
|
-0.63 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:37 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANVS documents filed with the SEC.
ANVS Filings
Clear
